(Total Views: 386)
Posted On: 03/26/2025 9:46:30 AM
Post# of 151575
Quote:
The trial you linked must have used allogenic (from the same patient) adult stem cells then dialed them back to a naive (fetal) pluripotent state. If they hadn't you'd see some level of rejection or GVHD.
The trial uses iPSC derived neural stem/progenitor cells for spinal cord injury. The cells are super donor derived from iPSC Stock Project out of Kyoto University. Immunosuppressants only until 6 months post transplantation. Interesting development.
(1)
(0)Scroll down for more posts ▼
